Individuals taking Mounjaro were three times as likely to lose 15% or more of total body weight, 2.5 times as likely to experience 10% or more weight loss, and 1.8 times as likely to experience 5% or more weight loss compared to those taking semaglutide, the active ingredient found in Ozempic
Importantly, Willard and colleagues (JCI Insight, 2020) demonstrated that tirzepatide is a biased agonist at GLP-1R, favouring G protein signalling over -arrestin recruitment, a property that may attenuate receptor desensitisation during chronic exposure
Every 10 lb of weight loss can lower systolic pressure by 57 mmHg
Memory Acetyl-L-Carnitine May Help Sharpen Your Memory New research on ALCAR combined with Vinpocetine and Huperzine-A
Medical patients may access Ipamorelin under physician-monitored peptide therapy through licensed HRT clinics
How Semaglutide Supports Weight Loss Semaglutide is a medication that acts on GLP-1 receptors involved in appetite regulation and blood sugar control